Instituto de Estudios de Mastocitosis de Castilla La Mancha Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01297777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now